Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform

Conexeu Sciences Inc. (Nasdaq: CNXU) (“ Conexeu” or the “Company”), a biotechnology company advancing tissue regeneration, announced the opening of its new research and development facility at adMare ...
The Lancet

FDA-cleared artificial intelligence and machine learning-based medical devices and their ...

aInstitute for Diagnostic and Interventional Radiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland bDepartment of Nuclear Medicine, University Hospital Zurich and ...